Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis
- PMID: 22757744
- DOI: 10.1111/j.1464-410X.2012.11292.x
Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis
Abstract
Different studies have shown the importance of citrate in the formation of calcium stones. It has further been shown that the states of metabolic acidosis result in an increase in bone resorption and lower urinary citrate levels. Increasing the intake of citrate in these patients can reduce the lithogenic risk and improve bone mineral density (BMD), contributing to control of both diseases. The study shows the importance of citrate in patients with calcium stones and BMD loss. The deficit in citrate excretion is associated with a decrease in bone mineralization and increased β-crosslaps. A calcium : citrate ratio >0.25 in patients with calcium stones and loss of mineral density may predict severe lithogenic activity.
Objective: To analyse the importance of urinary citrate and the urinary calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis compared with a control group of patients without lithiasis.
Material and methods: A cross-sectional study of 115 patients in eastern Andalusia, Spain was conducted. The patients were divided into two groups: Group A: 56 patients aged 25-60 years without calcium renal lithiasis; Group B: 59 patients aged 25-60 years, presenting with calcium renal lithiasis and severe lithogenesis. The citrate levels and the calcium : citrate ratio in the patients' urine and the relationship of these two factors to lithiasic activity were analysed and compared.
Results: In Group B, 32.2% of the patients presented with hypocitraturia, compared with 14.3% of the patients in Group A (P = 0.02). The urinary citrate levels were lower in Group B than in Group A (P = 0.001) and the calcium : citrate ratio was higher in Group B than in Group A (P = 0.005). The results suggest that a patient urinary calcium : citrate ratio > 0.25 indicates severe lithogenesis (with a sensitivity of 89% and a specificity of 57%). After linear regression analysis, we found that the urinary citrate level is an independent factor associated with the changes in bone densitometry T-score values of patients.
Conclusions: The patients with severe lithogenesis presented with hypocitraturia, which was associated with lower bone mineral density. The calcium : citrate ratio, which is linearly related to the bone resorption marker β-crosslaps, could be useful in evaluating the risk of severe lithogenesis when this ratio is >0.25.
© 2012 BJU International.
Comment in
-
Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis.BJU Int. 2013 Apr;111(4):529-30. doi: 10.1111/j.1464-410X.2012.11293.x. Epub 2012 Jul 3. BJU Int. 2013. PMID: 22757770 No abstract available.
Similar articles
-
Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis.BJU Int. 2013 Apr;111(4):529-30. doi: 10.1111/j.1464-410X.2012.11293.x. Epub 2012 Jul 3. BJU Int. 2013. PMID: 22757770 No abstract available.
-
Biochemical determinants of severe lithogenic activity in patients with idiopathic calcium nephrolithiasis.Urology. 2012 Jan;79(1):48-54. doi: 10.1016/j.urology.2011.07.1382. Epub 2011 Sep 9. Urology. 2012. PMID: 21908029
-
Mineral density and bone remodelling markers in patients with calcium lithiasis.BJU Int. 2011 Dec;108(11):1903-8; discussion 1908. doi: 10.1111/j.1464-410X.2011.10167.x. Epub 2011 May 9. BJU Int. 2011. PMID: 21554525
-
Calcium renal lithiasis and bone mineral density. Importance of bone metabolism in urinary lithiasis.Actas Urol Esp. 2013 Jun;37(6):362-7. doi: 10.1016/j.acuro.2012.10.003. Epub 2013 Feb 12. Actas Urol Esp. 2013. PMID: 23411066 Review. English, Spanish.
-
Calcium nephrolithiasis and bone demineralization: pathophysiology, diagnosis, and medical management.Curr Opin Urol. 2014 Nov;24(6):633-8. doi: 10.1097/MOU.0000000000000111. Curr Opin Urol. 2014. PMID: 25188231 Review.
Cited by
-
Exploring the characteristics of gut microbiome in patients of Southern Fujian with hypocitraturia urolithiasis and constructing clinical diagnostic models.Int Urol Nephrol. 2023 Aug;55(8):1917-1929. doi: 10.1007/s11255-023-03662-6. Epub 2023 Jun 9. Int Urol Nephrol. 2023. PMID: 37294502
-
Evolution of bone mineral density in patients with idiopathic hypercalciuria: a 20-year longitudinal study.Pediatr Nephrol. 2021 Mar;36(3):661-667. doi: 10.1007/s00467-020-04754-6. Epub 2020 Sep 26. Pediatr Nephrol. 2021. PMID: 32980941
-
Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments.Pediatr Nephrol. 2021 Jan;36(1):83-91. doi: 10.1007/s00467-020-04693-2. Epub 2020 Jul 26. Pediatr Nephrol. 2021. PMID: 32712761 Free PMC article. Clinical Trial.
-
Development of a LC-MS/MS Method for the Simultaneous Detection of Tricarboxylic Acid Cycle Intermediates in a Range of Biological Matrices.J Anal Methods Chem. 2017;2017:5391832. doi: 10.1155/2017/5391832. Epub 2017 Sep 18. J Anal Methods Chem. 2017. PMID: 29075551 Free PMC article.
-
Bone remodeling markers as lithogenic risk factors in patients with osteopenia-osteoporosis.Int Urol Nephrol. 2016 Nov;48(11):1777-1781. doi: 10.1007/s11255-016-1361-5. Epub 2016 Jul 4. Int Urol Nephrol. 2016. PMID: 27376897
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical